How to Get Testosterone Enanthate in California

Who Can Prescribe Testosterone Enanthate in California

Any California-licensed physician (MD or DO), nurse practitioner, or physician assistant with prescriptive authority can write a prescription for testosterone enanthate. California's Business and Professions Code grants NPs independent practice authority as of January 1, 2023, meaning NPs who meet the state's transition-to-practice requirements no longer need a supervising physician to prescribe Schedule III controlled substances like testosterone 1.

PAs in California prescribe under a practice agreement with a supervising physician, per Business and Professions Code Section 3502.1. For testosterone enanthate specifically, the prescriber must document a clinical indication. The Endocrine Society's 2018 Clinical Practice Guideline recommends testosterone replacement only for men with "unequivocally low serum testosterone levels and clinical signs and symptoms of testosterone deficiency" [2]. That guideline forms the baseline standard of care for most California prescribers.

Choosing between provider types is largely a matter of access. Endocrinologists and urologists carry the deepest expertise in hormonal management, but primary care physicians, NPs, and PAs handle the majority of TRT prescriptions nationally. A 2020 cross-sectional study published in JAMA Internal Medicine found that primary care providers wrote 56.8% of all testosterone prescriptions in the United States 3. Wait times for California endocrinology appointments can stretch 8 to 12 weeks, so starting with a primary care clinician or a telehealth TRT platform often gets treatment underway faster.

Lab Work Required Before a California Prescription

Two morning total testosterone levels below 300 ng/dL on separate days are the diagnostic threshold the Endocrine Society uses for male hypogonadism 2. California prescribers follow this standard almost universally. Blood draws must occur before 10 a.m. because testosterone exhibits a diurnal rhythm, peaking in early morning and declining 20 to 25% by afternoon 4.

Beyond total testosterone, expect the following panel:

• Free testosterone (calculated or equilibrium dialysis)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to distinguish primary from secondary hypogonadism
• Complete blood count (CBC) to establish a baseline hematocrit (testosterone raises red blood cell production)
• Comprehensive metabolic panel (CMP) including liver enzymes
• Lipid panel
• Prostate-specific antigen (PSA) for men over 40

Quest Diagnostics and Labcorp operate hundreds of draw sites across California. Many telehealth TRT providers will order labs through these networks or accept recent results (within 6 months) from another provider. Turnaround is typically 2 to 4 business days. The T-Trials, a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine, confirmed that testosterone treatment in men 65 and older with serum testosterone <275 ng/dL improved sexual function, physical activity, and mood over 12 months 5. Those trials reinforced the lab-first approach to diagnosis.

Telehealth Testosterone Enanthate Prescriptions in California

California fully permits telehealth prescribing of testosterone enanthate. The state's telehealth parity law (California Business and Professions Code Section 2290.5) allows a provider-patient relationship to be established via synchronous video, and controlled substance prescriptions are permitted when the prescriber meets federal DEA telemedicine requirements 6.

A typical telehealth TRT workflow in California looks like this:

1. Complete an intake questionnaire online.
2. Get lab work drawn at a local facility (ordered by the telehealth provider or self-pay).
3. Attend a video consultation where the provider reviews symptoms, labs, and medical history.
4. If clinically appropriate, receive an e-prescription sent to a California pharmacy or the platform's partnered compounding pharmacy.

From initial signup to first injection, most patients report a timeline of 5 to 14 days, depending on lab turnaround.

The American Urological Association's 2018 guideline states that "testosterone therapy should be offered to men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" 7. Telehealth platforms apply this same clinical framework; the delivery mechanism changes, but the diagnostic standard does not.

One advantage of telehealth for California patients in rural counties (Modoc, Lassen, Inyo, and similar areas with limited endocrinology access) is the removal of geographic barriers. A patient in Alturas has the same access to a board-certified prescriber as someone in Los Angeles.

Pharmacy Options: Retail, Compounding, and Mail-Order

California patients can fill testosterone enanthate prescriptions through three main channels.

Retail pharmacies. CVS, Walgreens, Rite Aid, and independent pharmacies across California stock generic testosterone enanthate (200 mg/mL vials). Cash pricing for a 1 mL vial of 200 mg/mL testosterone enanthate typically runs $30 to $80 without insurance, though GoodRx-type discount cards can bring it under $25 at some locations.

503A compounding pharmacies. California's Board of Pharmacy licenses 503A compounding pharmacies that prepare patient-specific testosterone enanthate formulations 8. These pharmacies can customize concentration, carrier oil (to reduce injection-site reactions in patients sensitive to cottonseed or sesame oil), and volume. They can ship directly to patients within California under state board oversight.

Mail-order. Some insurers and telehealth platforms use mail-order pharmacies licensed in California. Shipments must comply with California's controlled substance mailing regulations. Expect 3 to 7 business days for delivery, with signature required.

The FDA-approved labeling for testosterone enanthate specifies intramuscular injection with dosing typically ranging from 50 to 400 mg every 2 to 4 weeks for replacement therapy [9]. Most modern TRT protocols favor 100 to 200 mg weekly (or split into twice-weekly injections) to minimize peak-trough fluctuations.

Insurance Coverage and Medi-Cal Prior Authorization

California's Medicaid program (Medi-Cal) covers testosterone enanthate for the diagnosis of male hypogonadism, but prior authorization is required 10. The PA process involves the prescriber submitting documentation of:

• Two confirmed low testosterone levels (drawn before 10 a.m.)
• Signs and symptoms of hypogonadism (fatigue, decreased libido, erectile dysfunction, loss of muscle mass)
• Exclusion of reversible causes (opioid use, obesity-related suppression, pituitary pathology)

Turnaround for PA decisions varies by managed care plan but typically takes 5 to 10 business days. Under California law (Health and Safety Code Section 1367.241), health plans must respond to non-urgent PA requests within 5 business days.

Commercial insurers in California (Blue Shield, Anthem, Kaiser, Health Net, and others) generally cover generic testosterone enanthate on formulary for ICD-10 code E29.1 (testicular hypofunction). Co-pays on most plans run $5 to $30 for a 90-day supply. Brand-name Delatestryl may require step therapy through the generic first.

A 2017 analysis in the Journal of Clinical Endocrinology & Metabolism found that mean out-of-pocket costs for testosterone injections in the U.S. were $47 per month for insured patients, compared to $120 per month for testosterone gel formulations 11. Injections remain the most cost-effective delivery method.

Dosing, Administration, and Monitoring in California

Standard testosterone enanthate dosing for hypogonadism is 100 to 200 mg injected intramuscularly once per week, or 50 to 100 mg twice weekly for more stable serum levels 2. The injection is typically self-administered in the gluteal or vastus lateralis muscle using a 22- to 25-gauge, 1- to 1.5-inch needle.

California providers should follow the Endocrine Society's monitoring schedule [2]:

• 3 to 6 months after initiation: repeat total testosterone (trough draw, morning of injection day), CBC with hematocrit, and symptom assessment
• 12 months: full panel including testosterone, CBC, CMP, lipid panel, and PSA (men over 40)
• Annually thereafter if levels are stable

Hematocrit monitoring is critical. Testosterone increases erythropoiesis, and hematocrit values exceeding 54% require dose reduction or temporary cessation. The T-Trials observed a mean hematocrit increase of 2.5 percentage points from baseline in the testosterone group 5. A retrospective cohort study of 3,422 men on testosterone therapy published in JAMA found that the incidence of polycythemia (hematocrit >52%) was 11.2% over 3 years 12.

Dr. Shalender Bhasin, principal investigator of the T-Trials and professor of medicine at Harvard Medical School, has stated: "Monitoring hematocrit is the single most important safety measure during testosterone therapy. The risk of thromboembolic events rises with sustained elevations above 54%" 5.

California-Specific Legal and Regulatory Considerations

Testosterone enanthate is a Schedule III controlled substance under both federal law (Controlled Substances Act) and California Health and Safety Code Section 11056. Prescriptions in California must meet these requirements:

• Written on a tamper-resistant prescription form (for paper prescriptions) or transmitted electronically via an approved e-prescribing system
• Limited to a 90-day supply per fill, with up to 5 refills within 6 months of the original prescription date
• Include the prescriber's DEA number, patient name, date of birth, and medication details

California's Prescription Drug Monitoring Program (CURES 2.0) requires prescribers to check the CURES database before writing a new controlled substance prescription 13. This step is straightforward for testosterone enanthate, a medication with relatively low diversion risk compared to Schedule II opioids, but the check is mandatory.

Self-injection is legal in California, and most TRT patients inject at home. Some clinics offer in-office injection services, particularly for the first dose to ensure proper technique. California does not require a separate sharps-disposal permit for individual patients; used needles can be placed in an FDA-cleared sharps container and disposed of through household hazardous waste programs or pharmacy take-back bins.

Potential Side Effects and Risk Mitigation

The FDA label for testosterone enanthate lists the following adverse reactions 9:

• Common (5 to 15% incidence): injection-site pain, acne, increased hematocrit, mood changes, and increased PSA
• Less common (1 to 5%): gynecomastia, peripheral edema, sleep apnea worsening, and changes in lipid profile (decreased HDL)
• Rare but serious: polycythemia-related thromboembolic events, hepatotoxicity (primarily with oral androgens, rare with injectables), and exacerbation of undiagnosed prostate cancer

The TRAVERSE trial (N=5,204), the largest cardiovascular safety study of testosterone therapy to date, found no statistically significant increase in major adverse cardiovascular events (MACE) in hypogonadal men aged 45 to 80 treated with testosterone gel versus placebo (hazard ratio 0.99; 95% CI 0.81 to 1.21) 14. This trial, published in the New England Journal of Medicine in 2023, largely resolved a decade-long safety debate.

Dr. Mohit Khera, professor of urology at Baylor College of Medicine, commented on the TRAVERSE results: "This trial should reassure clinicians that appropriately prescribed testosterone therapy does not increase cardiovascular risk in men with hypogonadism and preexisting or high risk for cardiovascular disease" 14.

Fertility is an important consideration. Exogenous testosterone suppresses spermatogenesis, often to azoospermia within 3 to 6 months. Men who wish to preserve fertility should discuss alternatives such as clomiphene citrate or human chorionic gonadotropin (hCG) with their prescriber before starting testosterone enanthate. The American Urological Association explicitly recommends against testosterone therapy in men actively trying to conceive 7.

Transferring a Prescription to California

Patients moving to California from another state can transfer an existing testosterone enanthate prescription if:

1. The prescription has remaining refills.
2. The receiving California pharmacy contacts the originating out-of-state pharmacy to verify and transfer the prescription.
3. The California pharmacist confirms the prescription meets California's tamper-resistant and controlled substance documentation standards.

California Board of Pharmacy regulations permit controlled substance prescription transfers between pharmacies, but only one transfer per prescription is allowed for Schedule III through V drugs 8. If refills are exhausted, the patient will need a new prescription from a California-licensed provider, which requires establishing care and providing lab documentation of ongoing hypogonadism.

For patients already on a stable TRT regimen, many telehealth providers can review prior lab work and prescribing history to expedite the new-patient process. Expect a 1 to 3 day turnaround once labs and records are submitted.